Brent MacGregor
Chief Executive Officer bij MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Vermogen: - $ op 31-03-2024
Profiel
Brent MacGregor is currently the Chief Executive Officer at Medical Developments International Ltd.
and an Independent Director at Dynavax Technologies Corp.
He previously held positions as the Chief Executive Officer-Influenza Vaccine at Novartis AG, Executive Director-Global Strategic Planning at Sanofi, and Senior Vice President-Global Commercial Operations at Seqirus USA, Inc. Mr. MacGregor has a graduate degree from The University of Reading, an undergraduate degree from Carleton University, and an MBA from Kellogg School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-05-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Brent MacGregor
| Bedrijven | Functie | Begin |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Director/Board Member | 17-07-2020 |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Chief Executive Officer | 01-11-2020 |
Eerdere bekende functies van Brent MacGregor
| Bedrijven | Functie | Einde |
|---|---|---|
| Seqirus USA, Inc. | Corporate Officer/Principal | 01-06-2020 |
| SANOFI | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Opleiding van Brent MacGregor
| The University of Reading | Graduate Degree |
| Carleton University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| SANOFI | Health Technology |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Seqirus USA, Inc. |
